BAZ BIOMEDIC CO., LTD

Driven by innovation and a commitment to improving health and life quality, BAZ BIOMEDIC JAPAN Co., Ltd. launched in January 2024 as the dynamic Japanese arm of the globally recognized Korean parent company, BAZ BIOMEDIC. The firm’s specialty lies in leveraging cutting-edge Needle-Free Jet Injector (NFJI) technology to revolutionize the aesthetic and wellness markets.

NFJI represents a major leap forward in drug delivery, originating from the advanced aerospace engineering research of CEO JAI-ICK YOH. His discovery in 2010—that high-density energy transmission could be adapted for medical devices—laid the groundwork for the jet-propelled delivery system that forms the foundation of the company’s product line. BAZ BIOMEDIC JAPAN applies this superior technology to the design, manufacturing, and distribution of advanced beauty and medical devices across Japan.

The company is headquartered in Minato-ku, Tokyo (RandL TAKANAWAGATEWAY), and employs 20 dedicated professionals under the leadership of Representative Director Hiroaki Endo. Beyond product development, BAZ BIOMEDIC JAPAN is a holistic partner to clinics, offering services such as seamless import representation for medical equipment, providing critical medical and market intelligence derived from their international network, and offering hands-on clinical training via qualified nursing personnel. This integrated approach ensures that they not only supply innovative technology but also actively contribute to the sustained growth and excellence of the Japanese medical landscape.